The strategic market sector of Vivos Inc. (formerly Advanced Medical Isotope Corporation) is therapeutic isotope applications. Currently, the Company is engaged in the development of
RadioGel™, an Yttrium-90 based brachytherapy device, for the treatment of tumors. Brachytherapy uses radiation to destroy cancerous tumors by placing a
radioactive isotope inside the treatment area.